2002Harbin Yike Daxue xuebaoRequires access

Killing effects of HSV-TK gene on human glioma mediated by cationic liposome

Cheng Chuang Shu

Open publisher page 0 citations

Abstract

Objective To observe HSV TK/ACV system killing human glioma transferred with cationic liposome.Methods The eukaryotic expressing vectors pCR3 TK cloned containing the HSV TK gene were transferred into TJ905 cells with cationic liposome,Lipofectamine.After transfection,G418 was used to select the positive clones.The killing of TJ905 glioma cells transfected with HSV TK was examined by MTT under various concentration of ACV.Results The increasing sensitivity level of the TK gene transferred glioma cell to ACV treatment was confirmed.ACV had a specific suppression and killing effects on the glioma cells transfected with TK gene.Conclusion Cationic liposome,Lipofectamine is safe,simple and effective in transferring gene.This indicates that HSV TK/ACV gene therapy of glioma may be studied by cationic liposome transferring PCR3 TK.Such treatment may be used as an innovative method for brain tumor therapy.

About this research paper

What this paper is about

Objective To observe HSV TK/ACV system killing human glioma transferred with cationic liposome.Methods The eukaryotic expressing vectors pCR3 TK cloned containing the HSV TK gene were transferred into TJ905 cells with cationic liposome,Lipofectamine.After transfection,G418 was used to select the positive clones.The killing of TJ905 glioma cells transfected with HSV TK was examined by MTT under various concentration of ACV.Results The increasing sensitivity level of the TK gene transferred glioma cell to ACV treatment was confirmed.ACV had a specific suppression and killing effects on the glioma cells transfected with TK gene.Conclusion Cationic liposome,Lipofectamine is safe,simple and effective in transferring gene.This indicates that HSV TK/ACV gene therapy of glioma may be studied by cationic liposome transferring PCR3 TK.Such treatment may be used as an innovative method for brain tumor therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe HSV TK/ACV system killing human glioma transferred with cationic liposome.Methods The eukaryotic expressing vectors pCR3 TK cloned containing the HSV TK gene were transferred into TJ905 cells with cationic liposome,Lipofectamine.After transfection,G418 was used to select the positive clones.The killing of TJ905 glioma cells transfected with HSV TK was examined by MTT under various concentration of ACV.Results The increasing sensitivity level of the TK gene transferred glioma cell to ACV treatment was confirmed.ACV had a specific suppression and killing effects on the glioma cells transfected with TK gene.Conclusion Cationic liposome,Lipofectamine is safe,simple and effective in transferring gene.This indicates that HSV TK/ACV gene therapy of glioma may be studied by cationic liposome transferring PCR3 TK.Such treatment may be used as an innovative method for brain tumor therapy.

Key concepts: Lipofectamine, Cationic liposome, Transfection, Glioma, Genetic enhancement, Liposome, Molecular biology, Gene delivery

Related papers

Back to paper searchBrowse research topicsOriginal source
Killing effects of HSV-TK gene on human glioma mediated by cationic liposome — Research Paper | ScholarLens